Sam Au is a senior lecturer in Bioengineering at Imperial College and a strong advocate of convergent science approaches to cancer. He completed his PhD in biomedical engineering from the university of Toronto and was a Tosteson Postdoctoral Fellow at Harvard Medical School and Massachusetts General Hospital. His research group focuses on developing customised microfluidic devices for cancer applications. He is also the founding director of the CRUK Microfabrication and Prototyping Facility, founder of the MRes in Cancer Technology Programme, and director of the MRes in Medical Device Design and Entrepreneurship Programme at Imperial College.